IOM report can set the stage for improvements in pain care, says APS

The American Pain Society (APS) said that "Relieving Pain in America: A Blueprint for Transforming Prevention, Treatment, and Research, the report submitted to Congress today by the Institute of Medicine, is a major step forward in addressing the nation's leading public health problem - untreated and undertreated chronic pain. APS will make further comments after its leadership has had time to review the entire report.

"The IOM already has succeeded in focusing attention on Capitol Hill to the plight of millions of Americans who endure persistent, often severe pain every day," said Charles J. Inturrisi, PhD, past president of APS. "Pain is a serious and often neglected public health problem that voraciously drains our health care resources. Pain is responsible for inestimable lost wages, impaired worker productivity, and extracts a tragic personal toll on patients and their families."

Inturrisi added that the IOM report can set the stage for improvements in pain care, research and education and also communicate to policy makers and opinion leaders that pain is a major national public health problem that must be addressed with aggressive action.

The broad task for the IOM Pain Committee was to study the current state of science in pain research, patient care and education and explore new approaches to help advance the field. It is the first comprehensive, high-level government look at pain as a prominent public health problem in the United States.

"APS is encouraged that several strong policy initiatives could emerge from recommendations in the IOM report," said Inturrisi, "especially recognition of the benefits of multidisciplinary pain care and improved pain education and training for physicians."

He added that APS hopes the IOM report will spur action on the part of the medical, dental, nursing and other health professional training communities to more fully integrate pain in their curricula.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triptans better at relieving migraine pain than recently marketed and more expensive drugs